Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
77°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alimera Sciences Inc
(NQ:
ALIM
)
5.590
+0.010 (+0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alimera Sciences Inc
< Previous
1
2
3
Next >
60 Biggest Movers From Yesterday
August 17, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of...
Via
Benzinga
Alimera Sciences, inc (ALIM) Q2 2021 Earnings Call Transcript
August 13, 2021
ALIM earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: Alimera Sciences Q2 Earnings
August 13, 2021
Shares of Alimera Sciences (NASDAQ:ALIM) moved higher by 5.3% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 252.94%...
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For August 13, 2021
August 13, 2021
Companies Reporting Before The Bell • Jaguar Health (NASDAQ:JAGX) is expected to report quarterly loss at $0.03 per share on revenue of $7.28 million. • Fangdd...
Via
Benzinga
How Does Alimera Sciences's Debt Look?
August 11, 2021
Over the past three months, shares of Alimera Sciences (NASDAQ:ALIM) fell by 3.92%. Before we understand the importance of debt, let us look at how much debt Alimera...
Via
Benzinga
35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021
May 27, 2021
RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be...
From
MicroCap Rodeo
Via
AccessWire
Alimera Sciences Inc (ALIM) Q1 2021 Earnings Call Transcript
April 29, 2021
ALIM earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
Recap: Alimera Sciences Q1 Earnings
April 28, 2021
Shares of Alimera Sciences (NASDAQ:ALIM) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 162.50% over the...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
Week In Review: Sinopharm Transfers $4.6 Billion In Assets, Including Two COVID-19 Vaccines
April 17, 2021
Sinopharm Group will transfer six of its vaccine companies to Beijing Tiantan Biological Products. Two of the transferring companies have approved COVID-19 vaccines, and Sinopharma said a public...
Via
Talk Markets
Exposures
COVID-19
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
10 Biggest Price Target Changes For Thursday
April 15, 2021
Raymond James lifted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $750. NVIDIA shares rose 1.9% to $622.39 in pre-market trading. Barclays raised the price target...
Via
Benzinga
Alimera, Ocumension Ink Licensing Pact For Fluocinolone Acetonide Eye Implant In China
April 14, 2021
Ocumension Therapeutics has inked an exclusive license agreement for Alimera Sciences Inc's (NASDAQ: ALIM) 0.19mg fluocinolone acetonide...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.